Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind st
about
Focus on renal congestion in heart failureCurrent strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approachVasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?The effects of medications on circulating levels of cardiac natriuretic peptidesA patient with heart failure and worsening kidney functionContinuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease.Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.Intravenous fluids in acute decompensated heart failure.Comparing Sodium Intake Strategies in Heart Failure: Rationale and Design of the Prevent Adverse Outcomes in Heart Failure by Limiting Sodium (PROHIBIT) Study.Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart FailureDecompensated heart failure.Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.Repeated assessment of physical biomeasures or blood biomarkers for the definition of volume status and cardiac loading in LVSD.Cardiorenal syndrome: diagnosis, treatment, and clinical outcomes.Current treatment in acute and chronic cardio-renal syndrome.Management and monitoring of haemodynamic complications in acute heart failure.Can we improve the treatment of congestion in heart failure?Tolvaptan for the treatment of heart failure: a review of the literature.Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.Causes and treatment of oedema in patients with heart failure.Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature.Newest additions to heart failure treatment.Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.When to increase or reduce sodium loading in the management of fluid volume status during acute decompensated heart failure.Pharmacologic Approaches to Electrolyte Abnormalities in Heart Failure.Vasopressin receptor antagonists in patients with chronic heart failure.Evolving treatment strategies for management of cardiorenal syndrome.Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure.Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.B-type natriuretic peptide predicts postdischarge prognosis in elderly patients admitted due to cardiogenic pulmonary edema.NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial.Effect of Hypertonic Saline 5% on Early Graft Function and Urinary Interleukin 18 and Neutrophil Gelatinase-Associated Lipocalin in Deceased-Donor Kidney Transplantation.Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?
P2860
Q26769905-AEEEF517-575E-4226-8B8E-8805CC393DB6Q26822842-2D1F1214-2923-4AE0-AF2A-3CB13BC0CFB2Q28071921-FE3D6638-8507-464E-9830-4BFDF2250DB3Q28212913-F7268A31-94E1-42C3-ABC6-65C087554476Q34292920-CBFD95F7-4CB9-4402-B766-AD6F8B0EE80EQ34486006-12DA08DF-278C-4C33-815A-5C3D71E663BDQ35109039-09790C66-DB1B-4391-BFA9-10664F363468Q35151512-F48160CD-F53E-4DB0-8A15-1FF9D55AC4A9Q35628665-FCDA5DCC-AC3B-45EB-B39D-59D7C05C02A6Q35635411-84868EB7-3FB9-490B-9B2F-43CE0E4BB819Q36014073-D7FAB32B-6550-4235-BD15-04BD09B3219CQ36254209-0A36CF4C-E144-4169-8196-BD98A87090AEQ36931450-8000691A-BC2F-4573-86C7-465CCE65A56FQ37092258-080D827A-CB48-4938-BBBA-2C42DC3D8BDEQ37755071-E6D9317C-E69E-4FF8-94D8-63A08652CE01Q37782283-2B5B9390-2B79-428C-899C-54203F22903BQ37817025-BB8DB2E1-AD16-4488-A776-E510CAA7E826Q37837657-22F98DC6-C029-4730-8AFC-170FDA9E0B7EQ37845856-5707BCD4-B6CB-4ADF-9E93-797AF2587F61Q37852720-0F6F7924-71F5-4B0C-9016-49F97779C3CFQ37877721-C9E70DE6-D200-4502-B3DB-61A4A7C640A6Q38074093-1E53643B-DC93-47D5-AB18-55998A48E538Q38200507-8632D4F0-5645-4B16-8DF8-50D2CA28B17AQ38225739-116A7ADE-5C38-419D-ADA3-F50C6221395FQ38307958-03FDF464-FD44-4741-A679-80A32AB8BB76Q38611602-AD0BB486-51B2-434F-AEDD-6C83AF116438Q38859478-8BE2EBB0-3EB9-4B53-A997-11B1BF7FB948Q38954498-4CA56C79-6C4E-47F8-803F-E9B638A85462Q39258545-67216330-CF40-408F-BE6A-DD1A3DD3F29BQ40775380-1F5E8A10-B369-4484-BA8E-D584A7A666FDQ41608275-AA226646-452D-427E-9991-A6A6218530ABQ47315412-FDDD161F-4AA9-4472-8496-8C7CCD3D85ECQ47799890-7CA4C2EF-0660-4CFA-A023-B59536413290Q48468476-EDE33996-70CA-42C0-83FF-EE34DA5A773DQ48475891-54975896-9F30-4EC5-9EBB-F1B90565B681Q52649799-4D162FC8-962A-4528-B531-4CE6936A4A28Q55346961-9C01B0FD-403D-431A-B7C2-A68BF0CA5754
P2860
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind st
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Changes in brain natriuretic p ...... art failure: a double-blind st
@en
Changes in brain natriuretic p ...... art failure: a double-blind st
@nl
type
label
Changes in brain natriuretic p ...... art failure: a double-blind st
@en
Changes in brain natriuretic p ...... art failure: a double-blind st
@nl
prefLabel
Changes in brain natriuretic p ...... art failure: a double-blind st
@en
Changes in brain natriuretic p ...... art failure: a double-blind st
@nl
P2093
P1476
Changes in brain natriuretic p ...... art failure: a double-blind st
@en
P2093
Ersilia Fornaciari
Francesca Di Gaudio
Gaspare Parrinello
Giuseppe Licata
Pietro Di Pasquale
Salvatore Paterna
Sergio Fasullo
P304
P356
10.1016/J.JACC.2005.01.059
P407
P577
2005-06-01T00:00:00Z